Stock Analiz

EW vs STE stock comparison

Edwards Lifesciences vs. STERIS · data as of November 13, 2026

Edwards Lifesciences (EW) has a market value of about $61.6B, STERIS (STE) about $25.7B. Over their latest twelve months Edwards Lifesciences had revenue of $6.7B and STERIS $6.2B.

On our five checks STERIS scores higher: 3.0 out of 5 (average) against 2.8 (average).

By area, the stronger company is Edwards Lifesciences on future growth; STERIS on track record; STERIS on shareholder returns.

STERIS is cheaper on earnings (P/E 31.4 vs. 60.5).

Edwards Lifesciences leads on 8 of the compared lines and STERIS on 15.

Side by side

EWSTE
Size and price
Market cap$61.6B$25.7B
Share price$107.15$264.32
Score
Overall score (of 5)2.83.0
Value00
Future growth42
Track record23
Financial health55
Shareholder returns35
Valuation
P/E (TTM)60.531.4
Forward P/E33.521.7
Price / free cash flow43.327.4
Price / sales9.24.2
EV / EBITDA35.816.2
PEG8.552.76
DCF value vs. price−64%−43%
Business
Revenue$6.7B$6.2B
Net income$1.0B$827M
Free cash flow$1.4B$937M
Net margin15.3%13.4%
Gross margin (5-yr avg.)79.6%43.9%
ROIC (5-yr avg.)16.0%6.8%
Growth
Revenue growth (1 yr)11.6%8.7%
Revenue growth (5 yrs, per year)6.7%13.8%
EPS growth (5 yrs, per year)7.1%11.4%
Balance sheet and payouts
Net cash (cash minus debt)$3.9B-$1.4B
Dividend yieldNone1.04%
Shareholder yield1.5%2.0%
Analysts
Upside to average target+6%+6%
Consensus ratingBuyBuy

Highlighted = the better figure on that line. Revenue, net income and free cash flow: EW TTM to September 30, 2026, STE TTM to September 30, 2026. Not investment advice.

Frequently asked questions

Which is the better stock, Edwards Lifesciences or STERIS?

We do not give buy or sell advice. On our five checks (value, growth, track record, financial health and shareholder returns) STERIS scores 3.0 out of 5 and Edwards Lifesciences 2.8; the table shows where each one is stronger.

Is Edwards Lifesciences cheaper than STERIS?

On trailing earnings, STERIS trades at a P/E of 31.4 and Edwards Lifesciences at 60.5, so STERIS is cheaper by this measure. A lower P/E can also reflect slower expected growth.

Which grows faster, Edwards Lifesciences or STERIS?

Over five years STERIS grew revenue about 13.8% a year and Edwards Lifesciences about 6.7% a year.

Which pays a higher dividend?

Edwards Lifesciences yields nothing (no dividend) and STERIS 1.04%.

Full Edwards Lifesciences analysis → Full STERIS analysis →

More comparisons

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.